Adipic Dihydrazide → Amikacin

HRID 2088289

反応式

HRID 2088289 の反応式
[CH2:1]1[C@@H:6]([NH:7][C:8]([C@@H:10]([OH:14])[CH2:11][CH2:12][NH2:13])=[O:9])[C@H:5]([O:15][C@H:16]2[O:21][C@H:20]([CH2:22][OH:23])[C@@H:19]([OH:24])[C@H:18]([NH2:25])[C@H:17]2[OH:26])[C@@H:4]([OH:27])[C@H:3]([O:28][C@H:29]2[O:34][C@H:33]([CH2:35][NH2:36])[C@@H:32]([OH:37])[C@H:31]([OH:38])[C@H:30]2[OH:39])[C@H:2]1[NH2:40].OS(O)(=O)=O.C(NN)(=O)CCCCC(NN)=O.C1[C@@H](N)[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)[C@@H](O)[C@H](O[C@H]2O[C@H](CN)[C@@H](O)C[C@H]2N)[C@H]1N.S([O-])([O-])(=O)=O.C1[C@@H](N)[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)[C@@H](O)[C@H](O[C@H]2O[C@H](CN)[C@@H](O)C[C@H]2N)[C@H]1N.S([O-])([O-])(=O)=O.CCC[C@H]1CN(C)[C@H](C(N[C@H]([C@@H](Cl)C)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)=O)C1.Cl.C1[C@@H](NC([C@@H](O)CCN)=O)[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)[C@@H](O)[C@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1N.S([O-])([O-])(=O)=O>>[CH2:1]1[C@@H:6]([NH:7][C:8]([C@@H:10]([OH:14])[CH2:11][CH2:12][NH2:13])=[O:9])[C@H:5]([O:15][C@H:16]2[O:21][C@H:20]([CH2:22][OH:23])[C@@H:19]([OH:24])[C@H:18]([NH2:25])[C@H:17]2[OH:26])[C@@H:4]([OH:27])[C@H:3]([O:28][C@H:29]2[O:34][C@H:33]([CH2:35][NH2:36])[C@@H:32]([OH:37])[C@H:31]([OH:38])[C@H:30]2[OH:39])[C@H:2]1[NH2:40]

参加物

6

反応物 5

HCID 66117Adipic DihydrazideHCID 5458175Amikacin Sulfate SaltHCID 86619106(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol sulfateHCID 86619108(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide sulfateHCID 131729235tobramycin sulfate clindamycin HCl

生成物 1

HCID 37768Amikacin

実験手順

Amikacin Sulfate (100 mg), DBM (200 mg), and 8 mg of adipic acid dihydrazide were placed into a beaker and mixed thoroughly. Oxidized dextran solution (Mw, 500,000; 66 mg/ml; 1 ml) was added to the mixture. Tobramycin-sulfate or tobramycin-sulfate/clindamycin-HCl (1/1) can be used in place of amikacin-sulfate.

後処理

  1. additionmixed thoroughly

出典と根拠

ORDレコード
ord-e8a153b381184861ba0042bb82837855
出典データセット
uspto-grants-2013_05
特許番号
US08435565B2

関連ノート

読み込み中…